Kuniko Sunami

1.8k total citations
47 papers, 638 citations indexed

About

Kuniko Sunami is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Kuniko Sunami has authored 47 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Kuniko Sunami's work include Cancer Genomics and Diagnostics (23 papers), Lung Cancer Treatments and Mutations (18 papers) and Lung Cancer Research Studies (7 papers). Kuniko Sunami is often cited by papers focused on Cancer Genomics and Diagnostics (23 papers), Lung Cancer Treatments and Mutations (18 papers) and Lung Cancer Research Studies (7 papers). Kuniko Sunami collaborates with scholars based in Japan, United States and United Kingdom. Kuniko Sunami's co-authors include Noboru Yamamoto, Hiroshi Nokihara, Yutaka Fujiwara, Takashi Kohno, Hirofumi Utsumi, Hidehito Horinouchi, Shintaro Kanda, Koji Tsuta, Yuichiro Ohe and Koh Furuta and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Kuniko Sunami

44 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuniko Sunami Japan 16 320 297 196 150 81 47 638
Douglas Adkins United States 8 360 1.1× 389 1.3× 89 0.5× 74 0.5× 79 1.0× 19 659
Alessandra Bisagni Italy 16 285 0.9× 259 0.9× 124 0.6× 172 1.1× 134 1.7× 51 765
Dengfeng Ren China 11 535 1.7× 346 1.2× 149 0.8× 180 1.2× 61 0.8× 47 825
Shafei Wu China 16 440 1.4× 338 1.1× 165 0.8× 172 1.1× 102 1.3× 59 720
Roman Groisberg United States 14 442 1.4× 385 1.3× 167 0.9× 191 1.3× 96 1.2× 50 742
Hanna Koseła-Paterczyk Poland 15 418 1.3× 431 1.5× 89 0.5× 217 1.4× 76 0.9× 75 780
Katherine A. Scilla United States 11 363 1.1× 290 1.0× 162 0.8× 136 0.9× 56 0.7× 25 583
Álvaro Taus Spain 18 540 1.7× 408 1.4× 227 1.2× 223 1.5× 73 0.9× 63 874
Ramón Palmero Spain 14 384 1.2× 328 1.1× 79 0.4× 159 1.1× 35 0.4× 50 646
Kyungsoo Jung South Korea 13 299 0.9× 400 1.3× 196 1.0× 224 1.5× 59 0.7× 20 663

Countries citing papers authored by Kuniko Sunami

Since Specialization
Citations

This map shows the geographic impact of Kuniko Sunami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuniko Sunami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuniko Sunami more than expected).

Fields of papers citing papers by Kuniko Sunami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuniko Sunami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuniko Sunami. The network helps show where Kuniko Sunami may publish in the future.

Co-authorship network of co-authors of Kuniko Sunami

This figure shows the co-authorship network connecting the top 25 collaborators of Kuniko Sunami. A scholar is included among the top collaborators of Kuniko Sunami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuniko Sunami. Kuniko Sunami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Tatsuya, Kuniko Sunami, Takafumi Koyama, et al.. (2025). Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing. Japanese Journal of Clinical Oncology. 55(7). 720–728. 1 indexed citations
2.
Koyama, Takafumi, Kuniko Sunami, Kazuki Sudo, et al.. (2024). Identification of barriers to implementation of precision oncology in patients with rare cancers. Cancer Science. 115(6). 2023–2035. 2 indexed citations
3.
Sunami, Kuniko, Takashi Kubo, Hitoshi Ichikawa, et al.. (2024). Leveraging non‐coding regions to guarantee the accuracy of small‐sized panel‐based tumor mutational burden estimates. Cancer Science. 115(12). 4045–4053.
4.
Mukohara, Toru, et al.. (2024). Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report. JCO Precision Oncology. 8(8). e2300649–e2300649. 1 indexed citations
5.
Shiraishi, Kouya, Takayuki Honda, Kuniko Sunami, et al.. (2024). Passive Smoking–Induced Mutagenesis as a Promoter of Lung Carcinogenesis. Journal of Thoracic Oncology. 19(7). 984–994. 4 indexed citations
6.
7.
Shimoi, Tatsunori, Kuniko Sunami, Natsuko Okita, et al.. (2023). Progress report of a cross‐organ and biomarker‐based basket‐type clinical trial: BELIEVE Trial. Cancer Science. 115(2). 555–563. 5 indexed citations
8.
Ishimaru, S, Tatsunori Shimoi, Kuniko Sunami, et al.. (2023). Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial. International Journal of Clinical Oncology. 29(2). 89–95. 4 indexed citations
9.
Yoshida, Teruhiko, Yasushi Yatabe, Ken Kato, et al.. (2023). The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan. Cancer Biology and Medicine. 21(1). 4 indexed citations
10.
Makise, Naohiro, Tatsunori Shimoi, Kuniko Sunami, et al.. (2022). Loss of H3K27 trimethylation in a distinct group of de‐differentiated chordoma of the skull base. Histopathology. 82(3). 420–430. 5 indexed citations
11.
Ikegami, Masachika, Takafumi Koyama, Kuniko Sunami, et al.. (2022). High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer. Molecular Cancer Therapeutics. 22(2). 227–239. 15 indexed citations
12.
Koyama, Takafumi, Kuniko Sunami, Takashi Kubo, et al.. (2022). Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice. Cancer Science. 113(12). 4300–4310. 20 indexed citations
13.
Sunami, Kuniko, Hideaki Bando, Yasushi Yatabe, et al.. (2021). Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA. Cancer Science. 112(9). 3911–3917. 19 indexed citations
14.
Takeyasu, Yuki, Hitomi Sumiyoshi Okuma, Yuki Kojima, et al.. (2021). Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors. JCO Precision Oncology. 5(5). 756–766. 22 indexed citations
15.
Okuma, Yusuke, Yasushi Goto, Fumiyoshi Ohyanagi, et al.. (2020). Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. Cancer Medicine. 9(20). 7418–7427. 14 indexed citations
16.
Yatabe, Yasushi, Kuniko Sunami, Kōichi Goto, et al.. (2020). Multiplex gene‐panel testing for lung cancer patients. Pathology International. 70(12). 921–931. 36 indexed citations
17.
Fujiwara, Yasuhiro, Noboru Yamamoto, Kuniko Sunami, et al.. (2019). P1.01-102 Actionable Gene Aberration and the Response of Matched Therapy Among Patients with Non-Small-Cell Lung Carcinoma. Journal of Thoracic Oncology. 14(10). S401–S401. 2 indexed citations
18.
Miura, Akihiro, Taisuke Mori, Akihiko Yoshida, et al.. (2018). Primary adenocarcinoma of the trachea revealing a mucinous bronchial gland cell origin. Pathology - Research and Practice. 214(5). 796–799. 11 indexed citations
19.
Sunami, Kuniko, Yoshiro Nakahara, Satoru Kitazono, et al.. (2017). Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma. Annals of Oncology. 28. v571–v572.
20.
Okuma, Hitomi Sumiyoshi, Hidehito Horinouchi, Shinsuke Kitahara, et al.. (2016). Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer. Clinical Lung Cancer. 18(2). 234–240.e2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas Adkins Breakdown of academic impact, for papers by Alessandra Bisagni Breakdown of academic impact, for papers by Dengfeng Ren Breakdown of academic impact, for papers by Shafei Wu Breakdown of academic impact, for papers by Roman Groisberg Breakdown of academic impact, for papers by Hanna Koseła-Paterczyk Breakdown of academic impact, for papers by Katherine A. Scilla Breakdown of academic impact, for papers by Álvaro Taus Breakdown of academic impact, for papers by Ramón Palmero Breakdown of academic impact, for papers by Kyungsoo Jung
Rankless by CCL
2026